Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients

Journal of Neuroscience Research

Volumn 81, Issue 3, 2005, Pages 426-435

  McLarnon, James G ^a   Choi, Hyun B ^a   Lue, Lih Fen ^c   Walker, Douglas G ^c   Kim, Seung U ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Ajou University   (South Korea)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

amyloid; Adenosine triphosphate; Alzheimer's disease; Human microglia; Platelet activating factor; Store operated channel Ca2+ entry

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; CALCIUM; CALCIUM CHANNEL; THROMBOCYTE ACTIVATING FACTOR;

ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM DEPLETION; CALCIUM SIGNALING; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN TISSUE; MICROGLIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; CALCIUM; CELLS, CULTURED; DRUG INTERACTIONS; FETUS; HUMANS; MICROGLIA; PEPTIDE FRAGMENTS; PLATELET ACTIVATING FACTOR; POSTMORTEM CHANGES; SIGNAL TRANSDUCTION; SPECTROMETRY, FLUORESCENCE;

EID: 25444473871     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20487     Document Type: Article

References (55)

1. Adunsky A, Baram D, Hershowitz M, Mekori YA. 1991. Increased cytosolic free calcium in lymphocytes of Alzheimer patients. J Neuroimmunol 33:167-172.
2. Akiyama H, Mori H, Saido T, Kondo H, Ikeda K, McGeer PL. 1999. Occurrence of the diffuse amyloid β-protein (Aβ) deposits with numerous Aβ-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia 25:324-331.
3. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
4. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. 1993. Cytotoxicity of microglia. Glia 7:111-118.
5. Begley JG, Duan W, Chan S, Duff K, Mattson MP. 1999. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J Neurochem 72:1030-1039.
6. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA. 2002. Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 70:357-360.
7. 2+ mobilization and COX-2 in human microglia. Glia 43:95-103.
8. Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE. 1999. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and prion proteins. J Neurosci 19:928-939.
9. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE. 2000. Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J Neurosci 20:558-567.
10. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. 1993. Microglia and cytokines in neurological disease with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
11. Eckert A, Forstl H, Zerfass R, Hennerici M, Muller WE. 1997. Free intracellular calcium in peripheral cells in Alzheimer's disease. Neurobiol Aging 18:281-284.
12. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. 1996. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382:716-719.
13. Etcheberrigaray R, Hirashima N, Nee L, Prince J, Govoni S, Racchi M, Tanzi RE, Alkon DL. 1998. Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol Dis 5:37-45.
14. Etcheberrigaray R, Ito E, Oka K, Tofel-Grehl B, Gibson GE, Alkon DL. 1993. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc Natl Acad Sci USA 90:8209-8213.
15. Fowler CJ, Cowburn RF, Garlind A, Winblad B, O'Neill C. 1995. Disturbances in signal transduction mechanisms in Alzheimer's disease. Mol Cell Biochem 149/150:287-292.
16. Gibson GE, Nielsen P, Sherman KA, Blass JP. 1987. Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients. Biol Psychiatry 22:1079-1086.
17. Gibson GE, Martins R, Blass J, Gandy S. 1996a. Altered oxidation and signal transduction systems in fibroblasts from Alzheimer's patients. Life Sci 59:477-489.
18. Gibson GE, Zhang H, Toral-Barza L, Szolosi S, Tofel-Grehl B. 1996b. Calcium stores in cultured fibroblasts and their changes with Alzheimer's disease. Biochim Biophys Acta 316:71-77.
19. Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J, Kirkpatrick J, Kuo LM, Roher AE. 1996. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 16:6021-6037.
20. Grone A, Alldinger S, Baumgartner W. 2000. Interleukin-1beta, -6, -12 and tumor necrosis factor-alpha expression in brains of dogs with canine distemper virus infection. J Neuroimmunol 110:20-30.
21. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
22. Guo Q, Furukawa K, Sopher BL, Pham DG, Xie J, Robinson N, Martin G, Mattson M. 1996. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitized PC12 cells to death induced by amyloid β-peptide. Neuroreport 8:379-383.
23. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PLR, Jones PK, Petersen RB, Perry G, Smith MA. 2001. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023.
24. in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MB Stricker BHC. 2001. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. New Engl J Med 345: 1515-1521.
25. 2+ mobilization is altered in fibroblasts from patients with Alzheimer's disease. Proc Natl Acad Sci USA 91:534-538.
26. Jope R, Song L, Li X, Powers R. 1994. Impaired phosphoinositide hydrolysis in Alzheimer's disease brain. Neurobiol Aging 15:221-226.
27. Katzman R. 1986. Alzheimer's disease. New Engl J Med 314:964-973.
28. Leissring MA, Akbari Y, Fanger CM, Cahalan MD, Mattson MP, LaFerla FM. 2000. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J Cell Biol 149:793-797.
29. Leissring MA, Parker I, LaFerla FM. 1999a. Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4,5-triphosphate-mediated calcium signals. J Biol Chem 274:32535-32538.
30. Leissring MA, Paul BA, Parker I, Cotman CW, LaFerla FM. 1999b. Alzheimer's presenilin-1 mutation potentiates inositol 1, 4,5-trisphosphate- mediated calcium signaling in Xenopus oocytes. J Neurochem 72: 1061-1068.
31. Lue LF, Brachova L, Walker DG, Rogers J. 1996. Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients. Neurobiol Aging 17:421-429.
32. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J. 1999. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155:853-862.
33. Lue LF, Rydel R, Brigham EF, Yang L, Hampel H, Murphy GM, Brachova L, Yan SD, Walker DG, Rogers J. 2001a. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35:72-79.
34. Lue LF, Walker DG, Brachova L, Beach T, Rogers J, Schmidt AM, Stern DM, Yan SD. 2001b. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease. Identification of a cellular activation mechanism. Exp Neurol 171:29-45.
35. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. 1992. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
36. Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD. 2000a. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23:222-229.
37. Mattson MP, Zhu H, Yu J, Kindy MS. 2000b. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J Neurosci 20:1358-1364.
38. McDonald DR, Brunden KR, Landreth GE. 1997. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci 17:2284-2294.
39. McDonald DR, Bamberger ME, Combs CK, Landreth GE. 1998. β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 18:4451-4460.
40. McGeer PL, Rogers J. 1992. Anti-inflammatory agents as a therapeutic approach in Alzheimer's disease. Neurology 42:447-449.
41. McGeer PL, McGeer EG. 1999. Inflammation in the brain in Alzheimer's disease: implications for therapy. J Leukoc Biol 65:409-415.
42. McLarnon JG, Helm J, Goghari V, Franciosi S, Choi HB, Nagai A, Kim SU. 2000. Anion channels modulate store-operated calcium influx in human microglia. Cell Calcium 28:261-268.
43. 2+ in human microglia. Neuroscience 91:343-352.
44. Mirra SS, Heyman A, McKeel D, Sumi SM, Grain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. 1991. The consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
45. Nagai A, Nakagawa E, Hatori K, Choi HB, McLarnon JG, Lee MA, Kim SU. 2001. Generation and characterization of immortalized microglial cell lines: expression of cytokines and chemokines. Neurobiol Dis 8:1057-1068.
46. Norenberg W, Langoscg PJ, Gebicke-Haerter PJ, Illes P. 1994. Characterization and possible function of adenosine 5′-triphosphate receptors in activated rat microglia. Br J Pharmacol 111:942-950.
47. Saitoh T, Horsburgh K, Masliah E. 1993. Hyperaccivation of signal transduction systems in Alzheimer's disease. Ann N Y Acad Sci 695:34-41.
48. Satoh JI, Lee YB, Kim SU. 1995. T cell co-stimulatory molecules B7-1 (CD80) and B7-2 (CD 86) are expressed in human microglia but not in astrocytes in culture. Brain Res 704:92-96.
49. Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JP, Parker WD, Tuttle JB. 1997. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J Neurosci 17:4612-4622.
50. Stewart WF, Kawas C, Corrada M, Metter EJ. 1997. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632.
51. Walker DG, Kim SU, McGeer PL. 1995. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res 40:478-493.
52. 2+ signaling in human microglia. Brain Res 842:159-165.
53. 2+ influx in human microglia. Cell Calcium 27:205-212.
54. Webster S, Bradt B, Rogers J, Cooper N. 1997. Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide. J Neurochem 69:388-398.
55. Yoo AS, Cheng I, Chung S, Grenfell TZ, Lee H, Pack-Chung E, Handler M, Shen J, Xia W, Tesco G, Saunders AJ, Ding K, Frosch MP, Tanzi RE, Kim TW. 2000. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27:561-572.